Overactive Bladder Clinical Trials in Chicago, Illinois

4 studies are recruiting for overactive bladder in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

    The objective of our multi-center randomized single-blind study is to examine the safety and effect of intra-detrusor OnabotulinumtoxinA injections at the time of holium laser enucleation of the prostate (HoLEP) in men with overactive bladder symptoms with and without urge incontinence.

    Stage
    Phase 2
    Ages
    18 to 89
    Site
    Northwestern Medicine, Chicago, Illinois
    Run by
    Northwestern University
  2. Percutaneous Nerve Evaluation Trial Time

    Sacral neuromodulation (SNM) was approved by the Food and Drug Administration (FDA) for the treatment of urgency incontinence (UUI) in 1998. One of two trial phase techniques are utilized prior to placement of the implantable pulse generator (IPG) to predict a patient's success with the device: a p…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Chicago, Chicago, Illinois
    Run by
    University of Chicago
  3. Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

    The goal of this clinical trial is to learn if a vaginal radiofrequency (RF) device called MORPHEUSV works to treat overactive bladder (OAB) in women. Researchers also want to learn how safe the device is for this indication. This study will include women ages 22 to 80 who have had OAB symptoms for…

    Stage
    Not phased
    Ages
    22 to 80
    Site
    University of Chicago Medicine Urogynecology, Chicago, Illinois
    Locations
    9 in total
    Run by
    InMode MD Ltd.
  4. A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

    A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Rush University, Chicago, Illinois
    Locations
    22 in total
    Run by
    Valencia Technologies Corporation

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.